Products
Online Inquiry
Regadenoson
Cat. No.:
0225LY-0655
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Regadenoson is a selective A2A adenosine receptor agonist and adenosine derivative that enhances myocardial perfusion by inducing coronary vasodilation; it is characterized by a longer half-life and higher A2A selectivity than adenosine, with minimal affinity for A2B and A3 receptors.
Synonym:
Lexiscan; 313348-27-5
CAS No.:
313348-27-5
Formula:
C15H18N8O5
Formula Weight:
390.35
Specification
Targets&IC50:
A2AR: 290 nM(Ki)
Relative Density:
1.98 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Regadenoson can be used in cardiovascular imaging research to study its role as a selective A2A adenosine receptor agonist.
Library Information
Target:
Adenosine receptor
Receptor:
A2A
Pathways:
GPCR/G protein signaling; Neuronal signaling
Plate Number:
AOCL-9
Plate Location:
d11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
255 mg/mL; 653.26 mM
